Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02664935
Recruitment Status : Recruiting
First Posted : January 27, 2016
Last Update Posted : January 19, 2021
Sponsor:
Collaborators:
Cancer Research UK
AstraZeneca
Pfizer
Experimental Cancer Medicine Centres
Mirati Therapeutics Inc.
Information provided by (Responsible Party):
University of Birmingham